Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population

doi:10.3748/wjg.v20.i47.17932

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12746)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

881

WORD

324

HTML

8300

Tables (1-4)

335

Sum=9840

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1248

Download

1658

Sum=2906

Dec 21, 2014 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (168)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine

World J Gastroenterol. Dec 21, 2014; 20(47): 17932-17940
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17932

Table 4 Odds ratios of non-alcoholic fatty liver disease compared with controls

	¹OR (95%CI)	²OR (95%CI)
All NAFLD vs all controls
Hyperlipidemia	2.19 (1.81-2.65)	1.37 (1.04-1.80)
Hypertension	2.98 (2.37-3.74)	1.49 (1.10-2.03)
Diabetes	2.97 (2.14-4.11)	1.68 (1.08-2.62)
MS	6.29 (4.78-8.28)	2.34 (1.65-3.31)
Central obesity	6.56 (5.16-8.33)	1.97 (1.38-2.80)
Lean-NAFLD vs lean controls
Hyperlipidemia	1.87 (1.28-2.73)	1.29 (0.80-2.09)
Hypertension	3.26 (2.08-5.10)	1.72 (1.00-2.96)
Diabetes	3.87 (2.11-7.08)	2.47 (1.14-5.35)
MS	5.38 (2.66-10.89)	3.19 (1.38-7.35)
Central obesity	2.37 (1.44-3.90)	2.17 (1.17-4.05)
Overweight-obese NAFLD vs overweight-obese controls
Hyperlipidemia	1.61 (1.22-2.12)	1.36 (0.96-1.91)
Hypertension	1.64 (1.20-2.24)	1.33 (0.92-1.93)
Diabetes	1.87 (1.21-2.91)	1.34 (0.80-2.27)
MS	2.43 (1.75-3.38)	1.89 (1.29-2.77)

¹OR: Crude OR; ²OR: Adjusted by age, sex, body mass index, smoking, alcohol consumption and physical activities. NAFLD: Non-alcoholic fatty liver disease; OR: Odds ratio; CI: Confidence interval; MS: Metabolic syndrome.

Citation: Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20(47): 17932-17940
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17932.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i47.17932